KOREA PHARMA Co., Ltd. (KOSDAQ: 032300)

Market Cap	173.53B
Revenue (ttm)	80.40B
Net Income (ttm)	2.99B
Shares Out	10.91M
EPS (ttm)	275.94
PE Ratio	57.66
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,780
Open	15,900
Previous Close	15,880
Day's Range	15,900 - 16,360
52-Week Range	14,550 - 29,450
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 134
• Stock Exchange: KOSDAQ
• Ticker Symbol: 032300